Noticias y Actividades de IRadimed

IRadimed es una de las ...

• Russell 3000;
• TOB Iconic 10,000.

IRadimed es una empresa que cotiza bajo el símbolo de cotización IRMD (US).

Ver el organigrama con sus 15 ejecutivos principales

Biografías más buscadas en IRadimed

• Roger Susi, Chairman of the Board, President and Chief Executive O...
• Anthony Vuoto, Director
• Hilda Scharen-Guivel, Independent Director

Recientes movimientos de ejecutivos en IRadimed

• Steve Kachelmeyer, Vice President of Regulatory and Quality Assurance, ha dejado la empresa  (noticia publicada el 15 de enero de 2025).

Crear su alerta
para seguir los movimientos de los ejecutivos en IRadimed.

IRadimed tiene 1.020 competidores entre los que se incluyen Philips (Países Bajos), Medtronic (Irlanda) y Thermo Fisher Scientific (Estados Unidos).

Popular M&A news in Equipos médicos

• Globus Medical has announced the acquisition of Nevro  (publicado el 4 de abril de 2025).
• Amboss acaba de anunciar una recaudación de fondos de 259 millones de dólares. (publicado el 3 de abril de 2025).
• Patricia Industries has announced the acquisition of Nova Biomedical  (publicado el 24 de marzo de 2025).

Otros contactos sugeridos en el sector Equipos médicos

• Volker Wetekam - Director en Elekta Instrument
• Andrew Elbardissi - Director en Medical Microinstruments
• Marc Casper - Chairman of the Board, President and Chief Executive Officer en Thermo Fisher Scientific

Saber más sobre el sector Equipos médicos

Últimos comunicados de prensa de IRadimed

• IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference — IRadimed
• IRADIMED Pay Now
• IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference — IRadimed
• IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share — IRadimed
• IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share — IRadimed
• IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global MarketTrading to commence effective on the market open June 14, 2024 — IRadimed
• IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results — IRadimed
• IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference — IRadimed
• IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share — IRadimed
• IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes — IRadimed
• View more press releases Close

Redes sociales sobre IRadimed

• IRadimed en Wikipedia, Google News y Yahoo Finance
• IRadimed en LinkedIn, Twitter y YouTube